ENTRY       D02217                      Drug
NAME        Raloxifene hydrochloride (JAN/USP);
            LY 156758;
            Evista (TN)
PRODUCT     EVISTA (Eli Lilly and Company)
  GENERIC   RALOXIFENE HYDROCHLORIDE (A-S Medication Solutions)
            RALOXIFENE HYDROCHLORIDE (American Health Packaging)
            RALOXIFENE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            RALOXIFENE HYDROCHLORIDE (Aphena Pharma Solutions - Tennessee)
            RALOXIFENE HYDROCHLORIDE (Aphena Pharma Solutions - Tennessee)
            RALOXIFENE HYDROCHLORIDE (Aphena Pharma Solutions - Tennessee)
            RALOXIFENE HYDROCHLORIDE (Aurobindo Pharma Limited)
            RALOXIFENE HYDROCHLORIDE (AvPAK)
            RALOXIFENE HYDROCHLORIDE (Bryant Ranch Prepack)
            RALOXIFENE HYDROCHLORIDE (Bryant Ranch Prepack)
            RALOXIFENE HYDROCHLORIDE (Bryant Ranch Prepack)
            RALOXIFENE HYDROCHLORIDE (Bryant Ranch Prepack)
            RALOXIFENE HYDROCHLORIDE (Bryant Ranch Prepack)
            RALOXIFENE HYDROCHLORIDE (Cadila Pharmaceuticals Limited)
            RALOXIFENE HYDROCHLORIDE (Cipla USA)
            RALOXIFENE HYDROCHLORIDE (Dr.Reddy's Laboratories)
            RALOXIFENE HYDROCHLORIDE (Exelan Pharmaceuticals)
            RALOXIFENE HYDROCHLORIDE (Major Pharmaceuticals)
            RALOXIFENE HYDROCHLORIDE (Modavar Pharmaceuticals LLC)
            RALOXIFENE HYDROCHLORIDE (NorthStar Rx LLC)
            RALOXIFENE HYDROCHLORIDE (ScieGen Pharmaceuticals)
            RALOXIFENE HYDROCHLORIDE (Teva Pharmaceuticals USA)
FORMULA     C28H27NO4S. HCl
EXACT_MASS  509.1428
MOL_WEIGHT  510.0442
CLASS       Hormonal agent
             DG01619  Estrogen receptor antagonist/modulator
              DG01621  Selective estrogen receptor modulator
            Musculo-skeletal system agent
             DG03232  Osteoporosis agent
REMARK      Therapeutic category: 3999
            ATC code: G03XC01
            Chemical structure group: DG00476
            Product (DG00476): D02217<JP/US> D10606<JP>
EFFICACY    Osteoporosis agent, Selective estrogen receptor modulator (SERM)
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Benzothiophene derivative
TARGET      NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]
  PATHWAY   hsa04915(2099+2100)  Estrogen signaling pathway
            hsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption
INTERACTION  
STR_MAP     map07043  Antineoplastics - hormones
            map07047  Osteoporosis drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
                G03XC Selective estrogen receptor modulators
                 G03XC01 Raloxifene
                  D02217  Raloxifene hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Selective Estrogen Receptor Modifying Agents
               Raloxifene
                D02217  Raloxifene hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D02217  Raloxifene hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Hormonal agent
              DG01619  Estrogen receptor antagonist/modulator
               DG01621  Selective estrogen receptor modulator
                DG00476  Raloxifene
                 D02217  Raloxifene hydrochloride
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG00476  Raloxifene
                D02217  Raloxifene hydrochloride
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D02217  Raloxifene hydrochloride
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               Estrogen receptor
                NR3A (ESR)
                 D02217  Raloxifene hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02217
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02217
            Drug groups [BR:br08330]
             Hormonal agent
              DG01619  Estrogen receptor antagonist/modulator
               DG01621  Selective estrogen receptor modulator
                DG00476  Raloxifene
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG00476  Raloxifene
DBLINKS     CAS: 82640-04-8
            PubChem: 7849276
            ChEBI: 50740
            LigandBox: D02217
            NIKKAJI: J553.049K
ATOM        35
            1   X   Cl   28.3116  -20.4635
            2   C8y C    19.6000  -24.7100
            3   C8x C    19.6000  -26.1100
            4   C8x C    20.7900  -26.8100
            5   C8y C    22.0500  -26.1100
            6   C8x C    22.0500  -24.7100
            7   C8x C    20.7900  -24.0100
            8   C5a C    18.4100  -24.0100
            9   C8y C    17.2200  -24.7100
            10  O5a O    18.4100  -22.6100
            11  O2a O    23.2400  -26.8100
            12  C1b C    24.4300  -26.1100
            13  C1b C    25.6200  -26.8100
            14  N1y N    26.8100  -26.1100
            15  C1x C    28.0000  -26.8100
            16  C1x C    29.2600  -26.1100
            17  C1x C    29.2600  -24.7100
            18  C1x C    28.0700  -24.0100
            19  C1x C    26.8100  -24.7100
            20  C8y C    16.1000  -23.8700
            21  S2x S    14.9800  -24.6400
            22  C8y C    15.4000  -25.9700
            23  C8y C    16.7300  -25.9700
            24  C8x C    14.6300  -27.1600
            25  C8y C    15.3300  -28.4200
            26  C8x C    16.7300  -28.4200
            27  C8x C    17.4300  -27.2300
            28  C8y C    16.1000  -22.4700
            29  C8x C    14.9100  -20.3700
            30  C8x C    14.9100  -21.7700
            31  C8x C    17.3600  -21.7700
            32  C8x C    17.3600  -20.3700
            33  C8y C    16.1000  -19.6700
            34  O1a O    16.1000  -18.2700
            35  O1a O    14.6200  -29.6266
BOND        38
            1     2   3 2
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     6   7 2
            6     2   7 1
            7     2   8 1
            8     8   9 1
            9     8  10 2
            10    5  11 1
            11   11  12 1
            12   12  13 1
            13   13  14 1
            14   14  15 1
            15   15  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19   14  19 1
            20    9  20 2
            21   20  21 1
            22   21  22 1
            23   22  23 1
            24    9  23 1
            25   22  24 2
            26   24  25 1
            27   25  26 2
            28   26  27 1
            29   23  27 2
            30   20  28 1
            31   29  30 2
            32   30  28 1
            33   31  32 1
            34   32  33 2
            35   29  33 1
            36   33  34 1
            37   28  31 2
            38   25  35 1
///
